Form 4: American Healthcare REIT Chief Investment Officer Files Intent to Sell Shares Under 10b5-1 Plan
Insider Transaction Report
American Healthcare REIT's Chief Investment Officer, Stefan K.L. Oh, has filed a Form 4 indicating an upcoming sale of 3,860 shares of common stock on June 30, 2025, at a price of $36.1 per share, pursuant to a 10b5-1 plan.
Summary
- Stefan K.L. Oh, Chief Investment Officer of American Healthcare REIT, Inc., has filed a Form 4 reporting a planned sale of 3,860 shares of common stock.
- The transaction is scheduled to occur on June 30, 2025, at a price of $36.1 per share.
- Following this planned transaction, Mr. Oh will directly beneficially own 95,671 shares of common stock.
- The sale is being conducted pursuant to a Rule 10b5-1(c) pre-arranged trading plan.
Sentiment
Score: 4
Explanation: The filing reports an insider sale of common stock by the Chief Investment Officer. While the transaction is pre-planned under a Rule 10b5-1 plan, insider selling can sometimes be perceived as a neutral to slightly negative signal regarding future stock performance, though it doesn't necessarily indicate a lack of confidence.
Positives
- NA
Negatives
- Chief Investment Officer Stefan K.L. Oh is planning to sell 3,860 shares of common stock.
- Insider selling, even if pre-planned under a 10b5-1 plan, can sometimes be interpreted by the market as a neutral to slightly negative signal regarding future stock performance.
Risks
- Potential for negative market perception due to insider selling, which could put downward pressure on the stock price, despite the sale being pre-planned under a Rule 10b5-1 plan.
Future Outlook
NA
Industry Context
NA
Comparison to Industry Standards
- NA
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
Legal Proceedings
- NA
Related Party Transactions
- Sale of 3,860 shares of common stock by Stefan K.L. Oh, Chief Investment Officer, to the open market, pursuant to a Rule 10b5-1 plan.
Stakeholder Impact
- Shareholders: Potential for slight negative sentiment due to insider selling, though mitigated by the pre-arranged 10b5-1 plan.
Next Steps
- NA
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Scheduled date for the sale of 3,860 shares of common stock by Stefan K.L. Oh. |
| 07/02/2025 | Date the Form 4 was signed and filed. |
Keywords
American Healthcare REIT, AHR, Form 4, insider trading, stock sale, Stefan K.L. Oh, Chief Investment Officer, 10b5-1 plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.